Adocia
Biotech improving protein drug formulations for diabetes & obesity and developing cell therapies.
ADOC | PA
Overview
Corporate Details
- ISIN(s):
- FR0011184241 (+1 more)
- LEI:
- 969500ZL79KYH9PTYP78
- Country:
- France
- Address:
- 115 AVENUE LACASSAGNE, 69003 LYON
- Website:
- https://www.adocia.com
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Adocia is a clinical-stage biotechnology company founded in 2005, specializing in the development of innovative treatments for metabolic diseases, primarily diabetes and obesity. The company's core focus is on creating novel formulations of already-approved therapeutic proteins, peptides, and hormones, such as insulin, to improve their performance. Its diverse pipeline targets type 1 and type 2 diabetes and obesity. Additionally, Adocia develops platforms for cell therapies, including immunoprotective scaffolds. The company's business model is to develop products and technologies to the human proof-of-concept stage before licensing them to commercial partners.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-02 10:34 |
Major Shareholding Notification
Déclaration d'intention (FS 225C1435)
|
French | 130.2 KB | ||
| 2025-09-02 10:30 |
Major Shareholding Notification
Franchissement de seuil
|
French | 111.8 KB | ||
| 2025-07-11 11:18 |
Major Shareholding Notification
Franchissements de seuil
|
French | 116.2 KB | ||
| 2025-06-12 18:00 |
Declaration of Voting Results & Voting Rights Announcements
Inside Information / Other news releases
|
English | 492.1 KB | ||
| 2025-06-12 18:00 |
Declaration of Voting Results & Voting Rights Announcements
Informations privilégiées / Autres communiqués
|
French | 491.7 KB | ||
| 2025-05-22 18:00 |
Regulatory News Service
Inside Information / Other news releases
|
English | 452.1 KB | ||
| 2025-05-22 18:00 |
Regulatory News Service
Informations privilégiées / Autres communiqués
|
French | 472.2 KB | ||
| 2025-05-21 18:00 |
Pre-Annual General Meeting Information
Informations privilégiées / Autres communiqués
|
French | 120.9 KB | ||
| 2025-05-21 18:00 |
Pre-Annual General Meeting Information
Inside Information / Other news releases
|
English | 130.5 KB | ||
| 2025-05-15 18:00 |
Declaration of Voting Results & Voting Rights Announcements
Inside Information / Other news releases
|
English | 474.1 KB | ||
| 2025-05-15 18:00 |
Declaration of Voting Results & Voting Rights Announcements
Informations privilégiées / Autres communiqués
|
French | 473.1 KB | ||
| 2025-05-14 18:00 |
Earnings Release
Inside Information / News release on accounts, results
|
English | 576.9 KB | ||
| 2025-05-14 18:00 |
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 531.5 KB | ||
| 2025-04-30 18:00 |
Registration Form
Inside Information / Other news releases
|
English | 473.1 KB | ||
| 2025-04-30 18:00 |
Registration Form
Informations privilégiées / Autres communiqués
|
French | 461.0 KB |
Automate Your Workflow. Get a real-time feed of all Adocia filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Adocia via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-03-21 | N/A | Other | Buy | 51,921 | 499,999.23 EUR |
| 2024-03-21 | N/A | Other | Buy | 15,576 | 149,996.88 EUR |
| 2023-12-29 | N/A | Other | Sell | 20,000 | 236,550.00 EUR |
| 2023-10-05 | N/A | Other | Sell | 50,000 | 400,000.00 EUR |
| 2023-09-20 | N/A | Other | Sell | 36,240 | 291,376.85 EUR |
| 2023-07-28 | N/A | Other | Buy | 220,264 | 999,998.56 EUR |
| 2023-07-28 | N/A | Other | Buy | 110 | 499.40 EUR |
